163 related articles for article (PubMed ID: 3149290)
1. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
Man in 't Veld AJ; Boomsma F; van den Meiracker AH; Julien C; Lenders J; Schalekamp MA
J Hypertens Suppl; 1988 Dec; 6(4):S547-9. PubMed ID: 3149290
[TBL] [Abstract][Full Text] [Related]
2. Effect of unnatural noradrenaline precursor on sympathetic control and orthostatic hypotension in dopamine-beta-hydroxylase deficiency.
Man in 't Veld AJ; Boomsma F; van den Meiracker AH; Schalekamp MA
Lancet; 1987 Nov; 2(8569):1172-5. PubMed ID: 2890807
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency.
Wassenberg T; Deinum J; van Ittersum FJ; Kamsteeg EJ; Pennings M; Verbeek MM; Wevers RA; van Albada ME; Kema IP; Versmissen J; van den Meiracker T; Lenders JWM; Monnens L; Willemsen MA
J Inherit Metab Dis; 2021 May; 44(3):554-565. PubMed ID: 33034372
[TBL] [Abstract][Full Text] [Related]
4. Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine beta-hydroxylase deficiency.
Thompson JM; O'Callaghan CJ; Kingwell BA; Lambert GW; Jennings GL; Esler MD
J Auton Nerv Syst; 1995 Nov; 55(3):198-206. PubMed ID: 8801271
[TBL] [Abstract][Full Text] [Related]
5. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD
Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
[TBL] [Abstract][Full Text] [Related]
6. Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase.
Mathias CJ; Bannister RB; Cortelli P; Heslop K; Polak JM; Raimbach S; Springall DR; Watson L
Q J Med; 1990 Jun; 75(278):617-33. PubMed ID: 2217667
[TBL] [Abstract][Full Text] [Related]
7. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
Carvalho MJ; van den Meiracker AH; Boomsma F; Man in 't Veld AJ; Freitas J; Costa O; de Freitas AF
J Auton Nerv Syst; 1997 Jan; 62(1-2):63-71. PubMed ID: 9021651
[TBL] [Abstract][Full Text] [Related]
8. Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency.
Biaggioni I; Robertson D
Lancet; 1987 Nov; 2(8569):1170-2. PubMed ID: 2890806
[TBL] [Abstract][Full Text] [Related]
9. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
Birkmayer W; Birkmayer G; Lechner H; Riederer P
J Neural Transm; 1983; 58(3-4):305-13. PubMed ID: 6420517
[TBL] [Abstract][Full Text] [Related]
10. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
Sakoda S; Suzuki T; Higa S; Ueji M; Kishimoto S; Matsumoto M; Yoneda S
Eur Neurol; 1985; 24(5):330-4. PubMed ID: 3932074
[TBL] [Abstract][Full Text] [Related]
11. Dopamine B hydroxylase deficiency responsible for severe dysautonomic orthostatic hypotension in an elderly patient.
Gentric A; Fouilhoux A; Caroff M; Mottier D; Jouquan J
J Am Geriatr Soc; 1993 May; 41(5):550-1. PubMed ID: 8486891
[TBL] [Abstract][Full Text] [Related]
12. L-Dihydroxyphenylserine (L-DOPS): a norepinephrine prodrug.
Goldstein DS
Cardiovasc Drug Rev; 2006; 24(3-4):189-203. PubMed ID: 17214596
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine precursor therapy in neurogenic orthostatic hypotension.
Kaufmann H; Saadia D; Voustianiouk A; Goldstein DS; Holmes C; Yahr MD; Nardin R; Freeman R
Circulation; 2003 Aug; 108(6):724-8. PubMed ID: 12885750
[TBL] [Abstract][Full Text] [Related]
14. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.
Mathias CJ
Clin Auton Res; 2008 Mar; 18 Suppl 1():25-9. PubMed ID: 18368304
[TBL] [Abstract][Full Text] [Related]
15. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
Azuma T; Suzuki T; Mizuno R; Tsujino S; Kishimoto S; Mizuta E; Ichikawa K
Acta Neurol Scand; 1988 May; 77(5):409-13. PubMed ID: 3137768
[TBL] [Abstract][Full Text] [Related]
16. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activity in humans.
Iwase S; Mano T; Kunimoto M; Saito M
J Auton Nerv Syst; 1992 Jun; 39(2):159-67. PubMed ID: 1430796
[TBL] [Abstract][Full Text] [Related]
17. The cause of eyelid ptosis, orthostatic hypotension and exercise intolerance.
Monnens L
Acta Paediatr; 2022 Jun; 111(6):1134-1136. PubMed ID: 35202494
[TBL] [Abstract][Full Text] [Related]
18. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
Hoeldtke RD; Cilmi KM; Mattis-Graves K
Clin Pharmacol Ther; 1984 Sep; 36(3):302-6. PubMed ID: 6432398
[TBL] [Abstract][Full Text] [Related]
19. The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance.
Tanaka H; Yamaguchi H; Mino M
Clin Auton Res; 1996 Aug; 6(4):189-93. PubMed ID: 8902314
[TBL] [Abstract][Full Text] [Related]
20. [Development of L-threo-DOPS, a norepinephrine precursor amino acid].
Katsube J; Narabayashi H; Hayashi A; Tanaka C; Suzuki T
Yakugaku Zasshi; 1994 Nov; 114(11):823-46. PubMed ID: 7853146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
